Here's some good news:
The ultimate goal for the use of GRNOPC1 is restore spinal cord
function by injecting hESC-derived oligodendrocyte progenitor cells
directly into the patient’s injured spinal cord.
Old NID
44309
test content here
Here's some good news:
The ultimate goal for the use of GRNOPC1 is restore spinal cord
function by injecting hESC-derived oligodendrocyte progenitor cells
directly into the patient’s injured spinal cord.
Please donate so science experts can write for the public.
At Science 2.0, scientists are the journalists, with no political bias or editorial control. We can't do it alone so please make a difference.
Donate with PayPal button
We are a nonprofit science journalism group operating under Section 501(c)(3) of the Internal Revenue Code that's educated over 300 million people.
You can help with a tax-deductible donation today and 100 percent of your gift will go toward our programs, no salaries or offices.